Scribd
Upload
98 views2 pages

Harm Etiology Worksheet Atsu

This document provides guidance on assessing the validity and importance of results from a harm study. It addresses whether the study groups were similar, outcomes were measured the same way, follow-up was complete, and if the results satisfy criteria for causation. It also evaluates the magnitude and precision of the association between exposure and outcome through metrics like relative risk, odds ratio, and number needed to harm. Finally, it considers applying the results to a specific patient by examining their risks, preferences, and available alternative treatments.

Uploaded by

Febianto
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
98 views2 pages

Harm Etiology Worksheet Atsu

This document provides guidance on assessing the validity and importance of results from a harm study. It addresses whether the study groups were similar, outcomes were measured the same way, follow-up was complete, and if the results satisfy criteria for causation. It also evaluates the magnitude and precision of the association between exposure and outcome through metrics like relative risk, odds ratio, and number needed to harm. Finally, it considers applying the results to a specific patient by examining their risks, preferences, and available alternative treatments.

Uploaded by

Febianto
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

HARM/AETIOLOGY WORKSHEET

Citation:

Are the results of this harm study valid?


Were there clearly defined groups of patients, similar in all
important ways other than exposure to the treatment or other
cause?

Were treatment exposures and clinical outcomes measured


the same ways in both groups (e.g., was the assessment of
outcomes either objective (e.g., death) or blinded to
exposure)?
Was the follow-up of study patients complete and long
enough?

Do the results satisfy some "diagnostic tests for causation"?


• Is it clear that the exposure preceded the onset of the
outcome?
• Is there a dose-response gradient?
• Is there positive evidence from a "dechallenge-
rechallenge" study?
• Is the association consistent from study to study?
• Does the association make biological sense?

Are the valid results from this harm study important?

How is the magnitude and precision of See below.


the association between the exposure
See below.
and outcome?

Download Clinical Adverse Outcome Totals


Calculator Present (Case) Absent (Control)
Exposed to the Yes a b a+b
Treatment (Cohort)
No c d c+d
(Cohort)
Totals a+c b+d a+b+c+d

In a randomized trial or cohort study: Relative Risk = RR = [a/(a+b)]/[c/(c+d)]

In a case-control study: Odds Ratio (or Relative Odds) = OR = ad/bc

For a cohort study the NNH (number needed to harm) =


1/ | (CER – EER) |
where CER = control group event rate and EER = exposed group event rate

In this study:

1
Absolute ‘Risk Number Needed to
Reduction’ Harm
ARR NNH

CER EER |(CER – EER)| 1/ARR

Should these valid, potentially important results of change the treatment of your patient?
Is our patient so different from those in the study that its
results cannot apply?

What are our patient’s risks of the adverse outcome? What


is out patient’s potential benefit from the therapy?

What are our patient’s preferences, concerns and


expectations from this treatment?

What alternative treatments are available?

Additional Notes:

You might also like